tiprankstipranks
Trending News
More News >
Advertisement
Advertisement
Moleculin Biotech accelerates recruitment in Phase 3 MIRACLE trial
PremiumThe FlyMoleculin Biotech accelerates recruitment in Phase 3 MIRACLE trial
22d ago
Moleculin Biotech Releases New Corporate Presentation
Premium
Company Announcements
Moleculin Biotech Releases New Corporate Presentation
23d ago
Moleculin Biotech Begins Phase 2B/3 MIRACLE Trial Enrollment
Premium
Company Announcements
Moleculin Biotech Begins Phase 2B/3 MIRACLE Trial Enrollment
23d ago
Optimistic Buy Rating for Moleculin Biotech Based on Promising Annamycin Data and Future Potential
PremiumRatingsOptimistic Buy Rating for Moleculin Biotech Based on Promising Annamycin Data and Future Potential
1M ago
Moleculin Biotech Completes Promising Annamycin Trial
Premium
Company Announcements
Moleculin Biotech Completes Promising Annamycin Trial
1M ago
Moleculin Biotech announces OS data from Phase 1B/2 clinical trial in AML
Premium
The Fly
Moleculin Biotech announces OS data from Phase 1B/2 clinical trial in AML
1M ago
Moleculin Biotech reports Q2 EPS (49c) vs. ($1.70) last year
PremiumThe FlyMoleculin Biotech reports Q2 EPS (49c) vs. ($1.70) last year
2M ago
Moleculin Biotech sees cash runway into Q4
Premium
The Fly
Moleculin Biotech sees cash runway into Q4
2M ago
Promising Developments in Annamycin Drive Buy Rating for Moleculin Biotech
Premium
Ratings
Promising Developments in Annamycin Drive Buy Rating for Moleculin Biotech
2M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100